• News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in dr reddys lab

Dr Reddy's Re-Launches Naproxen Sodium OTC Tablets In US Market

Dr Reddys Naproxen Sodium Tablets USP, 220 mg, will be available in multiple-pack sizes to allow consumers a variety of purchasing options.

Read More

Dr Reddy's Launches Generic Invanz Injection In US Market

The Invanz brand and generic market had US sales of approximately USD 205 million MAT (moving annual total) for the most recent twelve months ending in March 2021 according to IQVIA Health.

Read More

Dr Reddy's Gets 3 Observations From USFDA For US-Based API Plant

The audit of the company's active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed by the US Food and Drug Administration (USFDA), the Hyderabad-based drug major said in a regulatory filing.

Read More

Pfizer Moves US Court Against Aurobindo Pharma, Dr Reddy's On Cancer Drug

The generic companies assert the invalidity and non- infringement of two composition of matter patents and a method of use patent covering palbociclib, each of which expire in 2023

Read More

India Approves Avigan (Favipiravir) for COVID-19 Treatment

In India, GRA and Dr. Reddy’s will look to distribute Avigan® through private healthcare providers opting for a premium quality drug. The initial supply will contain the original Avigan®, made in Japan.

Read More

Dr Reddy's Net Profit Falls 13 % To Rs 579 Cr In June Quarter

The revenue went up 15 per cent at Rs 4,418 crore as against Rs 3,844 crore while earnings before interest, taxes, depreciation and amortisation (EBITDA) were up 2.5 per cent at Rs 1,162 crore in Q1 FY21 as compared to Rs 1,134 crore in Q1 FY20.

Read More

Dr Reddy's Completes Acquisition Of Wockhardt's Select Business Divisions

This deal is in line with our strategic focus on India and has paved a path for accelerated growth and leadership in the domestic market,

Read More

Dr Reddy's Fourth-quarter Profit Falls 19% On US Headwinds

Revenue from the generics business in North America, its biggest market, dropped 6 percent to Rs 14.49 billion due to price erosions and increased competition

Read More

Dr Reddy's Acquires 6 OTC Brands From Ducere Of US

Dr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum

Read More